Here we provide a selection of scientific publications related to IOZK immunotherapy. You can use the filters to make a selection according to tumor types and methods, or enter search terms.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002007-09-01 / J. Immunol. 2007 Sep;179(5):2860-9https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2007-09-01 / J. Immunol. 2007 Sep;179(5):2860-92007-09-01 00:00:002019-02-15 09:16:56Targeting molecular and cellular inhibitory mechanisms for improvement of antitumor memory responses reactivated by tumor cell vaccine
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002007-09-01 / Oncol. Rep. 2007 Sep;18(3):665-71https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2007-09-01 / Oncol. Rep. 2007 Sep;18(3):665-712007-09-01 00:00:002019-02-15 09:16:57Combined treatment of dendritoma vaccine and low-dose interleukin-2 in stage IV renal cell carcinoma patients induced clinical response: A pilot study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002007-08-28 / Ann. Nutr. Metab. 2007;51(4):301-23https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2007-08-28 / Ann. Nutr. Metab. 2007;51(4):301-232007-08-28 00:00:002007-08-28 00:00:00Contribution of selected vitamins and trace elements to immune function
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002007-08-20 / AIDS 2007 Aug;21(13):1683-92https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2007-08-20 / AIDS 2007 Aug;21(13):1683-922007-08-20 00:00:002007-08-20 00:00:00Levels of antigen processing machinery components in dendritic cells generated for vaccination of HIV-1+ subjects
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002007-08-01 / Int. J. Cancer 2007 Aug;121(3):467-73https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2007-08-01 / Int. J. Cancer 2007 Aug;121(3):467-732007-08-01 00:00:002019-02-15 09:24:08Immunotherapy with dendritic cells for prostate cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002007-08-01 / Int J Hyperthermia 2007 Aug;23(5):431-42https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2007-08-01 / Int J Hyperthermia 2007 Aug;23(5):431-422007-08-01 00:00:002007-08-01 00:00:00Laboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002007-08-01 / Int J Hyperthermia 2007 Aug;23(5):417-29https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2007-08-01 / Int J Hyperthermia 2007 Aug;23(5):417-292007-08-01 00:00:002007-08-01 00:00:00Benefits of superficial hyperthermia treatment planning: five case studies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002007-08-01 / Int J Hyperthermia 2007 Aug;23(5):451-6https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2007-08-01 / Int J Hyperthermia 2007 Aug;23(5):451-62007-08-01 00:00:002019-02-15 10:00:36Conformal radiotherapy plus local hyperthermia in patients affected by locally advanced high risk prostate cancer: preliminary results of a prospective phase II study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002007-08-01 / Int J Hyperthermia 2007 Aug;23(5):443-50https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2007-08-01 / Int J Hyperthermia 2007 Aug;23(5):443-502007-08-01 00:00:002019-02-15 08:35:23Weekly systemic cisplatin plus locoregional hyperthermia: an effective treatment for patients with recurrent cervical carcinoma in a previously irradiated area
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002007-08-01 / Eur. J. Immunol. 2007 Aug;37(8):2164-73https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2007-08-01 / Eur. J. Immunol. 2007 Aug;37(8):2164-732007-08-01 00:00:002019-02-15 09:15:10Robust CD4+ and CD8+ T cell responses to SIV using mRNA-transfected DC expressing autologous viral Ag
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002007-08-01 / Cancer Biother. Radiopharm. 2007 Aug;22(4):501-7https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2007-08-01 / Cancer Biother. Radiopharm. 2007 Aug;22(4):501-72007-08-01 00:00:002019-02-15 09:19:40Review: dendritic cell-based vaccine in the treatment of patients with advanced melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002007-08-01 / Cancer Res. 2007 Aug;67(15):7477-86https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2007-08-01 / Cancer Res. 2007 Aug;67(15):7477-862007-08-01 00:00:002019-02-15 08:50:19A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002007-07-24 / J. Natl. Cancer Inst. 2007 Aug;99(15):1188-99https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2007-07-24 / J. Natl. Cancer Inst. 2007 Aug;99(15):1188-992007-07-24 00:00:002020-06-23 09:34:42Role of tumor endothelium in CD4+ CD25+ regulatory T cell infiltration of human pancreatic carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002007-07-20 / Immunology 2007 Dec;122(4):615-22https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2007-07-20 / Immunology 2007 Dec;122(4):615-222007-07-20 00:00:002019-02-15 08:59:49Enhanced antitumour immunity by combined use of temozolomide and TAT-survivin pulsed dendritic cells in a murine glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002007-07-15 / Cancer Res. 2007 Jul;67(14):6531-4https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2007-07-15 / Cancer Res. 2007 Jul;67(14):6531-42007-07-15 00:00:002007-07-15 00:00:00Development of vaccines for high-risk ductal carcinoma in situ of the breast
Targeting molecular and cellular inhibitory mechanisms for improvement of antitumor memory responses reactivated by tumor cell vaccine
Combined treatment of dendritoma vaccine and low-dose interleukin-2 in stage IV renal cell carcinoma patients induced clinical response: A pilot study
Contribution of selected vitamins and trace elements to immune function
Dendritic cells reconstituted with a human heparanase gene induce potent cytotoxic T-cell responses against gastric tumor cells in vitro
Levels of antigen processing machinery components in dendritic cells generated for vaccination of HIV-1+ subjects
Localized hyperthermia combined with intratumoral dendritic cells induces systemic antitumor immunity
Immunotherapy with dendritic cells for prostate cancer
Laboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapy
Benefits of superficial hyperthermia treatment planning: five case studies
Conformal radiotherapy plus local hyperthermia in patients affected by locally advanced high risk prostate cancer: preliminary results of a prospective phase II study
Dendritic cell vaccination
Weekly systemic cisplatin plus locoregional hyperthermia: an effective treatment for patients with recurrent cervical carcinoma in a previously irradiated area
Robust CD4+ and CD8+ T cell responses to SIV using mRNA-transfected DC expressing autologous viral Ag
Immunity of unloaded dendritic cells in lung melanoma of mice
Review: dendritic cell-based vaccine in the treatment of patients with advanced melanoma
A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model
Immunotherapy for prostate cancer using antigen-loaded antigen-presenting cells: APC8015 (Provenge)
Role of tumor endothelium in CD4+ CD25+ regulatory T cell infiltration of human pancreatic carcinoma
Enhanced antitumour immunity by combined use of temozolomide and TAT-survivin pulsed dendritic cells in a murine glioma
Development of vaccines for high-risk ductal carcinoma in situ of the breast